Phosphodiesterase 3 Inhibitor [EPC]

6228 reported adverse events

Drugs of this class: CILOSTAZOL ENSIFENTRINE

These side effects are most commonly reported by patients taking drugs of the Phosphodiesterase 3 Inhibitor [EPC] class:

# Side effect Count
0 DYSPNOEA 595
1 DIARRHOEA 433
2 DRUG INEFFECTIVE 367
3 PNEUMONIA 330
4 DEATH 310
5 FALL 274
6 NAUSEA 266
7 FATIGUE 241
8 OFF LABEL USE 239
9 HEADACHE 234
See all common reactions for Phosphodiesterase 3 Inhibitor [EPC]

Drugs of the Phosphodiesterase 3 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERIPHERAL ARTERY OCCLUSION 22 0.0156
1 INTERMITTENT CLAUDICATION 20 0.0126
2 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 49 0.0120
3 LACUNAR INFARCTION 21 0.0088
4 PERIPHERAL VASCULAR DISORDER 35 0.0068
5 HYPERPARATHYROIDISM SECONDARY 17 0.0068
6 THROMBOSIS IN DEVICE 21 0.0064
7 NEPHROGENIC ANAEMIA 28 0.0060
8 CEREBRAL INFARCTION 118 0.0048
9 PRODUCT COLOUR ISSUE 23 0.0045
See all enriched reactions for Phosphodiesterase 3 Inhibitor [EPC]